AERIE PHARMACEUTICALS INC

Historical 13F Holders

CUSIP
00771V108
All holders as of
Q3 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q3 161 47.0 M $711 M
2022 Q2 140 47.1 M $354 M
2022 Q1 143 48.1 M $437 M
2021 Q4 142 47.4 M $333 M
2021 Q3 148 46.3 M $528 M
2021 Q2 147 45.7 M $732 M
2021 Q1 164 46.6 M $831 M
2020 Q4 160 46.1 M $622 M
2020 Q3 155 46.9 M $552 M
2020 Q2 167 48.9 M $719 M
2020 Q1 169 54.1 M $735 M
2019 Q4 187 58.3 M $1.41 B
2019 Q3 188 56.7 M $1.09 B
2019 Q2 193 48.6 M $1.44 B
2019 Q1 188 47.6 M $2.26 B
2018 Q4 177 50.0 M $1.80 B
2018 Q3 205 49.0 M $3.02 B
2018 Q2 194 43.9 M $2.96 B
2018 Q1 189 43.3 M $2.35 B
2017 Q4 196 38.4 M $2.30 B
2017 Q3 200 37.8 M $1.84 B
2017 Q2 183 34.5 M $1.81 B
2017 Q1 169 32.5 M $1.47 B
2016 Q4 160 33.9 M $1.28 B
2016 Q3 184 32.6 M $1.23 B
2016 Q2 110 27.8 M $490 M
2016 Q1 109 26.6 M $324 M
2015 Q4 123 24.6 M $596 M
2015 Q3 126 24.7 M $444 M
2015 Q2 116 23.9 M $419 M
2015 Q1 130 22.1 M $693 M
2014 Q4 99 21.7 M $641 M
2014 Q3 78 20.7 M $411 M
2014 Q2 61 16.8 M $393 M
2014 Q1 53 14.1 M $299 M